From: Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker

ueRA | Healthy controls | |
---|---|---|

Number | 43 | 14 |

Female (n (%))
| 30 (69.7) | 9 (64.2) |

Age (years) ^{a,b,c}
| 61 (22–78) | 62.5 (35–72) |

Symptom duration (months) ^{a,b,d}
| 6 (2–23) | ND |

CRP (mg/L) ^{a,b}
| 9.1 (0.3–152) | ND |

ESR (mm/hour) ^{a,b}
| 26 (5–108) | ND |

Swollen joint count of 66 ^{a,b}
| 11 (2–30) | ND |

Tender joint count of 68 ^{a,b}
| 14 (3–47) | ND |

Swollen joint count of 28 ^{a,b}
| 9 (2–22) | ND |

Tender joint count of 28 ^{a,b}
| 9 (0–27) | ND |

DAS28-CRP ^{a,b}
| 5.1 (2.7–8) | ND |

DAS28-ESR ^{a,b}
| 5.3 (2.6–8.4) | ND |

CDAI ^{a,b}
| 28.1 (11.8–62.1) | ND |

ACPA ≥20 IU/ml (n (%))
| 34 (79) | ND |

RF ≥20 IU/ml (n (%))
| 33 (77) | ND |

ACPA ≥20 IU/ml + RF ≥20 IU/ml (n (%))
| 30 (70) | ND |

ACPA <20 IU/ml + RF <20 IU/ml (n (%))
| 5 (12) | ND |